COMP <GO>
RGEN vs QGEN // FORWARD P/E MULTIPLE
Repligen Corporation (NASDAQ) VS. Qiagen N.V. (NYSE) • 15-METRIC TALLY: RGEN 3
— QGEN 10
■ METRIC PARITY
LAST: $176.94 (-6.20%) • MKT CAP: $10.03B
forward-pe
—
LAST: $50.22 (-0.24%) • MKT CAP: $10.35B
forward-pe
22.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGEN VS. QGEN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RGEN | QGEN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.20% | 62.20% | +26.00 | RGEN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.30% | 8.00% | -5.70 | QGEN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 17.6x | +77.40 | QGEN | /valuation <GO> |
| Free Cash Flow Yield | 0.88% | 4.37% | -3.49 | QGEN | /fcf-yield <GO> |
| Operating Margin | 1.80% | 22.30% | -20.50 | QGEN | /operating-margins <GO> |
| Net Profit Margin | 1.60% | 20.30% | -18.70 | QGEN | /net-margins <GO> |
| Revenue Growth (YoY) | -3.30% | 5.70% | -9.00 | QGEN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.52% | -0.52 | QGEN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.31 | 3.54 | +5.77 | RGEN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | QGEN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.0 | 71.0 | -23.00 | QGEN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.95 | +0.09 | RGEN | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 22.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.03B | $10.35B | -$317.9M | QGEN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RGEN REV | QGEN REV | RGEN GROSS % | QGEN GROSS % | RGEN FCF | QGEN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $154.5M | $2.09B | — | 62.2% | $93.9M | $453.3M |
| FY 2024 | $98.3M | $1.98B | — | 48.9% | $149.7M | $506.4M |
| FY 2023 | $133.6M | $1.97B | — | — | $113.9M | $371.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGEN // BETA 1.04
QGEN // BETA 0.95